FDA approves Genentech’s ACTPen for giant cell arteritis
- Posted on: Nov 27 2018
- Leave a response
Genentech has landed FDA approval for a single-dose autoinjector filled with tocilizumab (Actemra ) for patients with giant cell arteritis (GCA).
Source: AAO
Posted in: Uncategorized